Tag Archives: Outcomes

Black women who live with the consequences of structural racism face poorer outcomes in mental health

There are ethnic inequalities in mental health and socioeconomic status amongst older women living with HIV in the UK, Dr Danielle Solomon reports in Sexually Transmitted Infections. The findings show that women of Black African and Black Caribbean origin are the most likely to experience poverty, psychological distress and social isolation, but are the least… Read More »

Almost half of HIV diagnoses in Europe are late, with serious impact on health outcomes

Almost half of HIV diagnoses in Europe are among people whose immune systems have already been seriously weakened by HIV, an international team of investigators report in BMC Infectious Diseases. Just under half a million people, half of them in Russia, are estimated to have received a late HIV diagnosis between 2010 and 2016. Late… Read More »

‘Hotspotting’ in healthcare has little to no effect on patient outcomes

The new healthcare practice of “hotspotting” — in which providers identify very high-cost patients and attempt to reduce their medical spending while improving care — has virtually no impact on patient outcomes or readmission rates, according to a new study led by MIT economists. The finding underscores the challenge of reducing spending on “superutilizers” of… Read More »

JAMA: Lower cost hospitals have similar patient outcomes as higher cost counterparts

Dive Brief: A new study in JAMA Network Open finds that Medicare patients with heart failure or pneumonia likely had more costs associated with the hospital where they were receiving treatment than their acuity. The researchers randomly studied 1.22 million patients discharged between July 2013 and June 2016, and further isolated them to 1,615 patient… Read More »

AHA: AstraZeneca’s Farxiga outcomes data looks even better in patients without diabetes

PHILADELPHIA––AstraZeneca’s SGLT2 med Farxiga has already stepped on the FDA fast track with trial data showing it could reduce heart failure risks in patients whether they have Type 2 diabetes or not. Turns out those “paradigm shifting” data show an even greater cardiovascular benefit for patients who don’t have diabetes than those who do—and this for a drug designed specifically to… Read More »